In 2018 Peter Moss, the grandfather of founder Adam Milton-Barker, was diagnosed terminally ill with Acute Myeloid Leukaemia. One month before his prognisis, Peter was given the all clear in a routine blood test with no signs of Acute Myeloid Leukaemia. Adam was convinced that there must have been signs in the routine blood test that could have identified the disease.
Adam had previous experience with using Artificial Intelligence for breast cancer detection through the Breast Cancer AI project, and wanted to see if this experience could be used to help with the detection of Acute Myeloid Leukaemia.
Adam created the Peter Moss Acute Myeloid & Lymphoblastic Leukaemia AI Research Project, an open-source research project dedicated to creating free technologies focused on the detection of Acute Myeloid & Lymphoblastic Leukaemia. The long term goal of the research project was to work towards Artificial Intelligence that could one day be used for early detection of the Leukaemia, an issue that remains under research globally and unsolved.
Since the research project began, we have published 13 open-source and free projects focused on the detection of Acute Lymphoblastic Leukaemia using Artificial Intelligence.
In August 2019, after battling Acute Myeloid Leukaemia for one day short of a year, Peter sadly passed away. This was a devastating time for the family, and made Adam determined to continue the research projects so that one day our technology and information could play a direct role in the lives of Leukaemia patients and their families.